Invirase - Big Patent Expirations of 2010

Drug: Invirase (saquinavir mesylate)
Company: Roche
Indication: HIV
Expiration Date: Nov. 19

Scoop: The patent covering Invirase, an HIV drug, expires this November. Currently, there are no generic products with tentative approval.

Invirase - Big Patent Expirations of 2010

Suggested Articles

Companies considering this avenue must think through potential implications despite the obvious attraction of early access for patients.

BD says a $1.2 billion investment in its pre-filled syringe business will add surge capacity needed to meet demand in future pandemics.

Ad Environment Matters for Message Receptivity